Full Text View
Tabular View
No Study Results Posted
Related Studies
Angiotensin II Blockade for Chronic Allograft Nephropathy
This study is ongoing, but not recruiting participants.
Study NCT00067990   Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First Received: September 3, 2003   Last Updated: August 6, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kidney Disease
Proteinuria
Additional conditions recognized in this trial
Kidney Diseases
More general conditions related to this trial
Signs and Symptoms
Urination Disorders
Urologic Diseases
Urological Manifestations
Interventions listed in this trial
Losartan
Additional drug interventions recognized in this trial
Angiotensin II
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Anti-Arrhythmia Agents
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services